Introduction
The platelet membrane glycoprotein Ib-IX-V (GPIb-IX-V) complex has a critical role in platelet adhesion mediating hemostasis. The complex is composed of 4 type 1 membrane-spanning proteins: GPIb␣, GPIb␤, GPIX, and GPV. Each of these glycoproteins is encoded by a single copy gene. The genes for GPIb␣ and GPIb␤ are located on chromosomes 17 and 22, respectively, 1,2 while the genes for GPIX and GPV are located on chromosome 3. 3, 4 GPIb␣ is disulfide linked to GPIb␤ 5, 6 ; GPIX and GPV are noncovalently associated with the complex. 7 It is known that GPIb␤ and GPIX are essential for the surface expression of the complex from experiments in cell lines and naturally occurring mutations 8, 9 and that the interaction of GPIb␤ with GPIX is essential for the surface expression of GPIb␣. There are no data on how GPIb␤ interacts with GPIX for the ordered surface expression of the complex. The von Willebrand factor (VWF) binds to the extracellular N-terminal domain of GPIb␣ (His1-Glu282), 10, 11 which contains 7 tandem leucine-rich repeats (LRRs) and has flanking disulfide looped sequences. GPIb␤ and GPIX are related to GPIb␣ and are very similar to GPIb␣ in their extracellular domains. Both GPIb␤ and GPIX have a single LRR. The amino-and carboxyl-terminal sequences flanking the LRR of GPIb␤ and GPIX are very similar to each other and to GPIb␣. In both of these regions, cysteines are conserved, suggesting conserved disulfide-loop structures. However, GPIb␤ and GPIX have 4 cysteines N-terminal to the LRR, as compared with 2 in GPIb␣. On the basis of homology with other LRR proteins, it has been suggested that these 4 cysteines form 2 disulfide loops with a loop-within-a-loop structure. 5 To explore the site(s) of interaction between GPIX and GPIb␤, we developed a novel series of antibodies to GPIb␤. We used site-directed mutagenesis to produce N-terminal truncations of GPIb␤ as well as GPI␤-IX chimeras to study the surface expression of the complex in mammalian cell lines.
Materials and methods

Monoclonal antibodies and reagents
Antibodies were produced as previously described. 12 Briefly, BALB/c mice were immunized with acrylamide slices excised from sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) gels containing reduced denatured platelet GPIb␤ immunopurified as a disulfide-linked complex with GPIb␣ by means of the monoclonal antibody (MoAb) AP-1. The anti-GPIb␣ antibody AP-1 blocks VWF binding to GPIb␣. From one fusion, a panel of 6 clones was obtained from which 4 were chosen since they reacted strongly with reduced platelet GPIb␤. The MoAb MBC 257.4 immunoblots both reduced and nonreduced platelet GPIb␤ and was used in the studies described below.
Anti-GPIX MoAbs FMC 25 and GRP were purchased from Harlan Bioproducts (Indianapolis, IN). AK1, a MoAb that recognizes an epitope on GPIX that requires the intact GPIb-IX complex, 13 was a generous gift of Dr Michael C. Berndt (Baker Medical Research Institute, Central Melbourne, Victoria, Australia). We have previously shown that this antibody requires the presence of GPIb␤ in cells stably transfected with GPIb␣ and GPIX to recognize the complex. 14 
Construction of expression vectors
We have previously described a Bernard-Soulier syndrome (BSS) patient who had a deletion of nucleotide 336 in GPIb␤ causing a frameshift and premature termination (GPIb␤-trunc). 9 This patient has no detectable GPIb␣ on the surface of his platelets and has the classical BSS phenotype. We used recombinantly expressed protein containing this mutation to identify the epitope for MBC 257.4. Full-length expression vectors containing GPIb␤ and full-length GPIX have previously been described. 9 N-terminal truncations of GPIb␤ were created by means of a strategy based on the type IIS restriction enzyme BsmBI. 15, 16 Since BsmBI creates a staggered cut on opposite strands of double-stranded DNA at 1 and 5 bases, respectively, 3Ј of its nonpalindromic recognition sequence (CGTCTC), any desired 4-base overhang can be created by placing sites at the 5Ј-end of polymerase chain reaction (PCR) primers. The nonhomologous recognition sequence is removed when digested. Thus left-and right-half pairs of PCR products designed with uniquely compatible cohesive ends can be merged seamlessly.
Full-length GPIb␤ was used as the amplification template in creating N-terminal truncations. The left-half PCR extended 3Ј from the flanking pCIneo sequence (pCIneo961 5ЈCTTGCGTTTCTGATAGGCACCT) through the signal peptide of GPIb␤. The right-half PCR extended from the point of the desired truncation through the remainder of GPIb␤ and into the other side of pCIneo (pCI1158 5Ј-ATTAACCCTCACTAAAGGGAAG ( Table 1 ). The numbering system used in the tables and "Results" refers to the first amino acids following the signal peptide.
PCR products were ligated into PCRII and sequenced to confirm fidelity. Then right-and left-half constructs were digested with XhoI and BsmBI and subcloned into the pCIneo expression vector at the XhoI/XbaI site, in a 3-fragment ligation.
GPIX/GPIb␤ chimeras were created with the use of wildtype plasmids as templates in a strategy in which 2 overlapping first-round PCRs are combined as templates for second-round reamplification to allow extension of a full-length complementary DNA. The first-round PCR products were amplified as follows: the N-terminal portion of the chimera was amplified from GPIX by means of a plasmid primer paired with a chimeric antisense primer containing approximately 20 bases of GPIX sequence followed by approximately 20 bases of GPIb␤ sequence, to produce a first-round product consisting of GPIX sequence up to the desired splice point, followed by a 20-base GPIb␤ overhang. The 3Ј (C-terminal) portion was amplified from a GPIb␤ plasmid in a similar manner with the use of a chimeric sense primer containing approximately 20 bases of GPIX overhang followed by GPIb␤ sequence complementary to the 20-base pair overhang produced in the previous PCR. The 2 first-round products anneal at the overlapping chimeric GPIX/␤ overhangs to serve as templates for second-round amplification. The final construct is amplified by means of flanking plasmid primers to produce a chimera consisting of GPIX and GPIb␤ ( Table 2 ).
Transient expression
For transient expression studies, HEK293T cells were used. The parent HEK293T cell line is a human renal epithelial cell, transformed with simian virus-40 large T antigen. 17 HEK293T cells were maintained at 37°C in a 5% CO 2 humidified chamber in modified Eagle media (Sigma, St Louis, MO) supplemented with 10% fetal calf serum. Expression plasmids were transfected into HEK293T cells in the presence of Lipofectamine and Lipfectamine Plus (GIBCO BRL, Rockville, MD) as described. 9 
Flow cytometry studies
Transfected cells were detached from tissue-culture plates with 3 mM EDTA, centrifuged at 250g, and resuspended in Hanks Balanced Salt Solution with 2% bovine serum albumin. Then, 3 ϫ 10 5 cells were transferred to each well of a 96-well V-bottom plate (Dynatech, Chantilly, VA) and incubated with either anti-GPIb␤ MoAb 257.4 (5 g/mL); the anti-GPIX MoAbs FMC-25 or GRP (5 g/mL); or the complex-specific MoAb AK1 (ascites 1:1200). The cells were then centrifuged, resuspended, and incubated for an additional 30 minutes in a darkened room with a 1:100 dilution of phycoerythrin-conjugated affinity-purified F(abЈ) 2 donkey antimouse immunoglobulin-G (IgG) (Jackson Immunoresearch Laboratories, West Grove, PA). The cells were then centrifuged and resuspended in 2% paraformaldehyde, allowed to incubate at least 1 hour at 4°C, and analyzed in a Becton Dickinson (San Jose, CA) FACScan flow cytometer.
Immunoblotting
Cell lysates were separated by SDS-PAGE on a 4% to 20% gradient gel according to Laemmli. 18 The separated proteins were electroblotted onto a polyvinylidine difluoride membrane (Novex, San Diego, CA) as described by Towbin et al, 19 blocked in phosphate-buffered saline (PBS) containing 5% powdered milk, and then incubated overnight with the anti-GPIb␣ MoAb MBC 257.4. The membrane was washed 3 times with PBS containing 5% powdered milk, incubated with a goat anti-mouse IgG conjugated with horseradish peroxidase, washed again 3 times, developed with SuperSignal Chemiluminescent Substrate (Pierce, Rockford, IL), and visualized by luminescent radiography. The BsmBI site is in underlined italics; the overhang is in bold. GP indicates glycoprotein. *Numbering is as follows: Amino acid 1 is the first amino acid following the signal peptide. The "new" N-terminus follows immediately after the signal peptide. From one anti-GPIb␤ fusion, a panel of 6 anti-GPIb␤ clones were obtained, of which 4 reacted strongly with reduced platelet GPIb␤ by Western blot. The MoAb MBC 257.4 was selected on the basis of its ability to immunoblot both reduced and nonreduced GPIb␤. The epitope of MBC 257.4 was evaluated in a series of experiments expressing known recombinant proteins. In a BSS patient we have previously characterized, we identified a single nucleotide deletion within the codon for Ala80 in GPIb␤. This mutation causes a translational frameshift, which encodes for 86 altered amino acids and predicts stop codon 15 amino acids short of the length of the wildtype protein.
HEK293T cells were transfected with this construct, lysed, run on SDS-PAGE, and reacted with MBC 257.4. MBC 257.4 recognized this expressed protein (Figure 1) , suggesting that the epitope for MBC 257.4 is within the N-terminal 80 amino acids of GPIb␤.
To further characterize the antibody, HEK 293T cells were transfected with a construct for GPIb␤ with sequential N-terminal deletions. The cells were then reacted with MoAb 257.4 and analyzed by flow cytometry. GPIb␤ constructs truncated at residues 14, 26, or 31 were readily detectable on the surface of cells transfected with the respective constructs. However GPIb␤ truncated at residues 58 and 65 was not detectable with MoAb 257.4 ( Figure 2 ). When the cells transfected with the N-terminal deletions 58 and 65 were reacted with an anti-GPIb␤ polyclonal antibody, there was no increase in surface fluorescence, further suggesting that these constructs were not surface expressed.
To further define the epitope for 257.4, we analyzed the binding of 257.4 to a series of GPIb␤/GPIX chimeras by flow cytometry. Chimeras were created where sequential N-terminal deletions of GPIb␤ were replaced with the corresponding structural domain of GPIX. This approach allowed us to more precisely define the binding region for MoAb 257.4. The cysteine knot at the N terminus of GPIb␤ (residues 1-14) was spliced and replaced with the cysteine knot region of GPIX, residues 1 through 22, to create chimera GPIX22/␤15. MoAb 257.4 bound to this chimera (Figure 3 ). The N terminus of GPIb␤ was truncated more distally at residue 31 and replaced with the homologous region from GPIX, chimera GPIX36/␤32. This chimera was detected on the surface of transfected cells with MoAb 257.4 ( Figure 3 ). The N terminus of GPIb␤ was truncated at residue 49 and replaced with the homologous region of GPIX, chimera GPIX53/␤49. This chimera was recognized by MoAb 257.4 ( Figure 3 ). Since GPIb␤ was replaced to residue 49 in these chimeras and the MoAb 257.4 reacted strongly with this chimera, this suggests that the epitope for the antibody lies distal to residue 49. This antibody also recognizes a recombinant mutant GPIb␤ with a translational frameshift at residue 80. Together, these results GPIb␤-trunc. 9 The epitope for MBC 257.4 is within the N terminus 80 residues of GPIb␤. For personal use only. on November 16, 2017. by guest www.bloodjournal.org From suggest that the epitope for MBC 257.4 is between residues 50 and 80 of GPIb␤. As discussed above, these truncations defined the epitope for MBC 257.4 and allowed us to explore more precisely the interactions of GPIb␤ with GPIX.
Complex formation of GPIb␤ with GPIX
Expression of GPIX with N-terminal truncations of GPIb␤.
To investigate the interaction of GPIb␤ with GPIX, plasmids encoding GPIb␤ and GPIX or wildtype GPIX with serial N-terminal truncations of GPIb␤ were transiently transfected into HEK293T cells. These cells were then incubated with an anti-GPIX MoAb, FMC25, followed by a phycoerythrin-conjugated donkey antimouse antibody, and then analyzed by flow cytometry.
When wildtype GPIb␤ and wildtype GPIX were simultaneously cotransfected into HEK 293T cells, GPIX were readily detectable on the cell surface (Figure 4) . However, when GPIb␤ truncated at residues 14 or 26 was cotransfected into HEK293T cells, GPIX was not detectable on the cell surface ( Figure 4B-C) , nor was there any increase in fluorescence when the cells were reacted with the complex-specific antibody AK1 (Figure 4E-F) . To determine if these truncations of GPIb␤ interacted with GPIb␣, GPIb␤ truncated at residue 26 and wildtype GPIb␣ were simultaneously transfected into HEK293T cells. The cells were immunoprecipitated with the anti-GPIb␣ antibody and immunoblotted with MBC 257.4. Since GPI␤⌬1-26 is present, this demonstrates that it is complexed with GPIb␣ ( Figure 5) .
Expression of GPIX with GPIb␤/GPIX chimeras. Since Nterminal truncations of GPIb␤ allowed the surface expression of GPIb␤ alone but did not bring GPIX to the surface, we explored the interaction of GPIb␤ with GPIX with a series of GPIb␤/GPIX chimeras. To control for potential conformational changes induced by deleting the N terminus of GPIb␤, we generated a series of chimeras between GPIb␤ and GPIX at defined boundaries. The cysteine knot at the N terminus of GPIb␤ (residues 1-14) was spliced and replaced with the cysteine knot region of GPIX (residues 1-22) to create chimera GPIX22/␤15. This chimeric construct was cotransfected simultaneously with wildtype GPIX. The cells were then reacted with the complex-specific antibody AK1. Chimera GPIX22/␤15 expressed on the cell surface ( Figure  3 ). When chimera GPIX22/␤15 was cotransfected into HEK293T cells simultaneously with GPIX, there was a significant increase in fluorescence when the cells were reacted with the complex-specific antibody AK1, suggesting that chimera GPIX22/␤15 interacts with GPIX to bring GPIX to the surface ( Figure 6 ).
In another chimeric construct, the N terminus of GPIb␤ was truncated more distally at residue 31 (N terminus to the LRR region) and replaced with the homologous region from GPIX, chimera GPIX36/␤32. 
GPIb␤ CYSTEINE KNOT AND
GPIb␤-GPIX INTERACTION 4431 BLOOD, 15 JUNE 2002 ⅐ VOLUME 99, NUMBER 12 For personal use only. on November 16, 2017. by guest www.bloodjournal.
org From
This chimera surface expresses (Figure 3 ), but does not interact with, GPIX (Figure 6 ) since it is not detected with AK1.
The N terminus of GPIb␤ was truncated at residue 49 (middle of the leucine-rich motif) and replaced with the homologous region of GPIX, chimera GPIX53/␤49; this chimera did surface express (Figure 3 ), but did not complex with, GPIX (Figure 6 ), as shown by the negative response when the cells are reacted with AK1. Thus, the residues 15 through 32 of GPIb␤ are critical for the interaction with GPIX.
Discussion
It has previously been shown, in experiments using recombinant expression in mammalian cell lines and in naturally occurring mutations, that the interaction of GPIb␤ with GPIX is essential for the normal surface expression of GPIb␣. 8, 9 The precise sites of interaction of GPIb␤ and GPIX are not known. To define the sites of interaction of GPIb␤ with GPIX, we made a new series of antibodies, which recognize GPIb␤. We demonstrated that one of these antibodies recognizes an epitope between residues 50 and 80 of GPIb␤. We then constructed a series of truncations of GPIb␤ at the amino terminus. These experiments suggested that the amino terminus was important for the interaction between GPIb␣ and GPIb␤. We then generated a series of chimeras, replacing the N terminus of GPIb␤ with the corresponding domain of GPIX, and demonstrate that the cysteine knot region of GPIb␤ is critical for the conformation of GPIb␤ that interacts with GPIX. Furthermore, we have shown that residues 15 through 32 of GPIb␤ are critical for the interaction of GPIb␤ with GPIX.
The secondary structures of GPIX and GPIb␤ have not yet been defined. It has been suggested that these regions are homologous to GPIb␣. 5 GPIb␣ has an N-terminal flank with a single cysteine loop, 7 LRRs, and a C-terminal flanking region containing 2 disulfide loops. GPIb␤ and GPIX have similar structural domains, with each containing a single LRR. It is interesting that the flanking amino acids on both sides of the LRR are homologous in the proteins of this group. It has been suggested by Hickey et al 20 that the flanking amino acid sequences on both sides of the region containing the LRR may represent the product of an ancestral oligonucleotide sequence in which the flanking segments -D) or the complex-specific antibody AK1 (panels E-H). Panels A and E are wildtype beta and wildtype IX. Panels B and F are the chimera GPIX22/␤15, which brings GPIX to the surface and is complexed to GPIX22/ ␤15 since there is a significant increase in surface fluorescence in these cells when reacted with the antibody AK1 as compared with mock-transfected cells. In contrast, when cells simultaneously transfected with chimeras GPIX36/␤32 (panels C, G) and GPIX53/49 (panels D, H) and GPIX are reacted with either the anti-GPIX (panels C, D) antibody or AK1 (panels G, H), there is no increase in fluorescence compared with mock-transfected cells. Thus, the N-terminal 14 residues of GPIb␤ are essential for the surface expression of GPIX.
remained constant and the central LRR underwent duplication. The results of the present investigation demonstrate a critical role for the N terminus-flanking region of GPIb␤ with GPIX.
Molecular characterization of the defects in BSS has helped define critical regions in the GPIb-IX complex. Our previous investigations have demonstrated that GPIb␤ is essential for the normal surface expression of GPIX. There are 4 published reports of mutations within GPIb␤ that cause the BSS phenotype. 9, 14, 21, 22 To date, there have been no descriptions of point mutations within the N-terminal flanking region of GPIb␤ that cause the syndrome. In contrast, 2 mutations that cause BSS have been described within the C-terminal flanking region of GPIX. 23, 24 It is unclear why point mutations in the N-terminal flanking region of GPIX give rise to the BSS phenotype. One explanation is that the mutation produces an unstable protein that fails to express. Alternatively, if this region of GPIX can no longer interact with GPIb␤, neither GPIb␣ nor GPIX would be detectable on the platelet surface. In the patient described by Rivera et al, 23 a homozygous T3C transition changed Cys83Arg. The results of our experiments suggest that this region of GPIX might no longer interact with GPIb␤, and hence GPIb␣ would not be expressed on the cell surface. Interestingly, Rivera et al noted circulating glycocalicin in their patient's plasma. This suggests that GPIb␣ was being made, yet not inserted in the plasma membrane. We have noted a similar finding in another BSS patient with a mutation in GPIb␤. 14 Wright et al 24 described 3 patients who were doubly heterozygous for mutations within GPIX. One mutation was an A3G transition in codon 21, and the other was an A3G change in codon 45. These mutations changed an Asp to Gly in the N terminus-flanking region of GPIX and an Asn to Ser within the LRR. Again, it was not clear how these mutations caused the BSS phenotype although the authors proposed that these mutations disrupted the stable assembly of the complex. Our results support their hypothesis. Mutations in GPIX that result from changes in the codons for cysteines on either flanking region of the LRR resulted in BSS. 23, 25 This mutation probably disrupts the disulfide bonding pattern in the amino terminus and hence altered the secondary structure of GPIX, which disrupts the proper assembly and anchoring of the complex. 23 In the present investigation, we used chimeras where the cysteine knots of both GPIb␤ and GPIX were preserved within each of the subunits by swapping precise structural domains. These results demonstrate the critical importance of this region for the precise insertion of the whole complex in the plasma membrane.
Dong et al 26 investigated assembly and transport of the entire GPIb complex using transfected mammalian cells. They showed that the full complex was formed within minutes in the endoplasmic reticulum. Surprisingly, they noted that GPIb␣, even in the complexed form, was highly susceptible to degradation. When GPIb␣ was expressed as a partial complex with either GPIb␤ or GPIX, more than 60% of GPIb␣ was degraded. In contrast, the partial complex consisting of GPIb␤ and GPIX was relatively stable. From our previous investigations on patients with BSS, we have shown that it is the critical interaction of GPIb␤ with GPIX that brings GPIb␣ to the surface. The present investigation extends our previous work and the analysis of complex assembly by Dong et al. 26 GPIX mutations appear to disrupt the GPIb/IX structure, as evidenced by exposure of a cryptic site on GPIb␤ 23 and decreased expression of GPIX thorough its failure to interact with GPIb␤. 24 Previous investigations on the role of GPIb␤ have been limited by a paucity of GPIb␤ antibodies. In this investigation, we made and characterized a novel anti-GPIb␤ antibody. While the results of this investigation further define the role of GPIb␤ in assembly of the complex, additional studies are required to further define the functional role of GPIb␤.
